Inke S.A: APIs manufacturing plant.
01 1INKE S.A.
02 1MSN Laboratories Private Limited
01 2Aclidinium Bromide
01 1India
02 1Spain
Inke S.A: APIs manufacturing plant.
NDC Package Code : 64567-0028
Start Marketing Date : 2022-01-13
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0027
Start Marketing Date : 2014-03-26
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
58
PharmaCompass offers a list of Aclidinium Bromide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Aclidinium Bromide manufacturer or Aclidinium Bromide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Aclidinium Bromide manufacturer or Aclidinium Bromide supplier.
A Eklira manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Eklira, including repackagers and relabelers. The FDA regulates Eklira manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Eklira API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Eklira manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Eklira supplier is an individual or a company that provides Eklira active pharmaceutical ingredient (API) or Eklira finished formulations upon request. The Eklira suppliers may include Eklira API manufacturers, exporters, distributors and traders.
click here to find a list of Eklira suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Eklira as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Eklira API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Eklira as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Eklira and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Eklira NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Eklira suppliers with NDC on PharmaCompass.
We have 2 companies offering Eklira
Get in contact with the supplier of your choice:
